Your browser doesn't support javascript.
loading
MicroRNA-186 promotes cell proliferation and inhibits cell apoptosis in cutaneous squamous cell carcinoma by targeting RETREG1.
Hu, Xinde; Liu, Yifeng; Ai, Ping; He, Shuguang; Liu, Lingzhi; Chen, Chaoying; Tan, Yuansheng; Wang, Ting.
Afiliação
  • Hu X; Clinical Laboratory, Second People's Hospital of Shaoyang City, Shaoyang, Hunan 422000, P.R. China.
  • Liu Y; Department of Dermatology, Second People's Hospital of Shaoyang City, Shaoyang, Hunan 422000, P.R. China.
  • Ai P; Department of General Surgery, Second People's Hospital of Shaoyang City, Shaoyang, Hunan 422000, P.R. China.
  • He S; Clinical Laboratory, First Affiliated Hospital of Hunan University of Chinese Medicine, Zhuzhou, Hunan 412000, P.R. China.
  • Liu L; Clinical Laboratory, First Affiliated Hospital of Hunan University of Chinese Medicine, Zhuzhou, Hunan 412000, P.R. China.
  • Chen C; Clinical Laboratory, First Affiliated Hospital of Hunan University of Chinese Medicine, Zhuzhou, Hunan 412000, P.R. China.
  • Tan Y; Hanpu Science and Teaching Park, Hunan University of Chinese Medicine, Changsha, Hunan 410208, P.R. China.
  • Wang T; Hanpu Science and Teaching Park, Hunan University of Chinese Medicine, Changsha, Hunan 410208, P.R. China.
Exp Ther Med ; 17(3): 1930-1938, 2019 Mar.
Article em En | MEDLINE | ID: mdl-30867688
ABSTRACT
MicroRNAs (miRs), a class of small non-coding RNAs, have been demonstrated to be involved in the development and progression of human malignancies, including cutaneous squamous cell carcinoma (CSCC). miR-186 serves a suppressive role in certain common types of human cancer; however, its exact function in CSCC has not been reported previously. In the present study, the expression of miR-186 was significantly increased in CSCC tissues compared with adjacent non-tumour tissues. Overexpression of miR-186 significantly promoted CSCC cell proliferation while inhibiting cell apoptosis. Reticulophagy regulator 1 (RETREG1), a gene that is significantly downregulated in CSCC tissues and cell lines, was identified as a novel target of miR-186. In addition, the expression of RETREG1 was inversely correlated with miR-186 expression in CSCC tissues. Furthermore, the expression of RETREG1 was negatively regulated by miR-186 in CSCC cells, and restoration of RETREG1 attenuated the effects of miR-186 on CSCC cells. Taken together, the results of the current study suggest that miR-186 serves an oncogenic role in CSCC and may be used as a potential therapeutic target for the treatment of this disease.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article